Emcure Pharmaceuticals Limited has published the extracts of its Audited Financial Results for the quarter and year ended March 31, 2026. This publication was made in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were published in the newspapers "Financial Express" and "Loksatta" on May 06, 2026. Additionally, these extracts of the newspaper publication are now available on the company's official website, www.emcure.com, for public access. Amruta Yangalwar, Company Secretary & Compliance Officer, has confirmed the filing and requested the stock exchanges to take this information on record.
